The ingredient is also approved to claim as a health benefit that it “helps stimulate the growth of healthy bacteria (such as bifidobacteria) in the intestine/gut.”
MSP Starch Products Inc. (MSP; Carberry, MB, Canada), announced that its resistant potato starch, Solnul, has secured Master File acceptance from Health Canada, allowing the ingredient to be sold as a prebiotic ingredient for Natural Health Products in the country. It is also approved to claim as a health benefit that it “helps stimulate the growth of healthy bacteria (such as bifidobacteria) in the intestine/gut.”
"This is a big win for resistant starch and for Canada. Getting Health Canada's approval is not just a great business achievement; it's also really meaningful to us,” stated chief growth officer of MSP Starch Products Inc., Jason Leibert, in a press release. “There's something special about selling right here at home, where we can directly support the health and well-being of Canadians while working toward our goal of bringing resistant starch back into modern diets.”
The ingredient is validated by a recent three-arm, randomized, double-blind, placebo-controlled clinical trial. The study found that consumption of 3.5 g per day of Solnul may produce a prebiotic effect. In the study, participants taking the resistant potato starch experienced significant changes in Bifidobacterium and Akkermansia after four weeks, compared to placebo.
Reference
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.